CIPLA
Back to Balance Sheet
|
CIPLA Last 5 Year Unsecured Loans History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Unsecured Loans | - | - | ₹-332 Cr | ₹40 Cr | ₹847 Cr |
What is the latest Unsecured Loans ratio of CIPLA ?
| Year | Unsecured Loans |
|---|---|
| Mar2025 | - |
| Mar2024 | - |
| Mar2023 | ₹-332 Cr |
| Mar2022 | ₹40 Cr |
| Mar2021 | ₹847 Cr |
How is Unsecured Loans of CIPLA Trending?
| Years | Unsecured Loans | % Change | |
|---|---|---|---|
| Mar2025 | - | 0 | |
| Mar2024 | - | 100.00 | |
| Mar2023 | ₹-332 Cr | Negative | |
| Mar2022 | ₹40 Cr | -95.28 | |
| Mar2021 | ₹847 Cr | - | |
Compare Unsecured Loans of peers of CIPLA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| CIPLA | ₹97,848.8 Cr | 0.8% | -9.1% | -13.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹396,370.0 Cr | -3.9% | -8.9% | -3.2% | Stock Analytics | |
| DIVIS LABORATORIES | ₹161,193.0 Cr | 3.8% | -4.7% | 11.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹141,438.0 Cr | 3.2% | -5.6% | 26.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹103,097.0 Cr | 3.3% | -6% | 11% | Stock Analytics | |
| MANKIND PHARMA | ₹85,841.5 Cr | 1.9% | -7.1% | -15.2% | Stock Analytics | |
CIPLA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| CIPLA | 0.8% |
-9.1% |
-13.1% |
| SENSEX | 3.7% |
-0.9% |
0.7% |
You may also like the below Video Courses